Literature reference · Neurology
Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
PubMed · Retrieved 2026-10-13
Bibliographic record: Ageing research reviews (2023 Aug). PMID 37328112. DOI 10.1016/j.arr.2023.101979.
Reference details
- Authors
- Joseph Nowell; Eleanor Blunt; Dhruv Gupta; Paul Edison
- Journal
- Ageing research reviews
- Publication date
- 2023 Aug
- PMID
- 37328112
- DOI
- 10.1016/j.arr.2023.101979
- Volume
- 89
- Pages
- 101979
- Language
- eng
- Publication types
- Journal Article; Review
- MeSH subjects
- Humans; Hypoglycemic Agents; Parkinson Disease; Incretins; Alzheimer Disease; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Neurodegenerative Diseases; Insulin; Inflammation; Neuroprotective Agents
Citation
Joseph Nowell; Eleanor Blunt; Dhruv Gupta; Paul Edison. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.. Ageing research reviews. 2023 Aug.
Indexed subjects
Humans • Hypoglycemic Agents • Parkinson Disease • Incretins • Alzheimer Disease • Diabetes Mellitus, Type 2 • Glucagon-Like Peptide-1 Receptor • Neurodegenerative Diseases • Insulin • Inflammation • Neuroprotective Agents
Access and reuse
This page presents bibliographic facts and links from the PubMed record. The publisher abstract and full article are not reproduced. Follow the source links to read the research and check its current status.
Sources and reuse
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2023-11-24. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.